Bemotrizinol, recently approved as a new active ingredient in sunscreens, is the first new ingredient for OTC sunscreen ...

Pregnancy may not be a risk factor for invasive melanoma or melanoma in situ, though women of reproductive age may be at an increased risk.

The addition of microneedling to topical minoxidil for the treatment of women with androgenetic alopecia provides no ...

The FDA has assigned a Prescription Drug User Fee Act (PDUFA) target action date of February 23, 2027. The Food and Drug Administration (FDA) has accepted for review the supplemental New Drug ...

In a health service area with more than 4 dermatologists per 100,000 population vs areas with no dermatologists, the proportion of late-stage melanoma diagnoses was reduced by 20%. Higher ...